BONE BIOLOGICS CORPORATION
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-11.9M | $24.1K |
| FY2020 | — | $-13.7M | — |
| FY2021 | — | $6.6M | $6.7M |
| FY2022 | — | $5.9M | — |
| FY2023 | — | $2.9M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-11.9M | $24.1K |
| FY2020 | — | $-13.7M | — |
| FY2021 | — | $6.6M | $6.7M |
| FY2022 | — | $5.9M | — |
| FY2023 | — | $2.9M | — |